563 related articles for article (PubMed ID: 21803102)
1. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
2. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF; Brown RM; Roodman ST
J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
[TBL] [Abstract][Full Text] [Related]
3. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ravn P; Boesen H; Pedersen BK; Andersen P
J Immunol; 1997 Feb; 158(4):1949-55. PubMed ID: 9029137
[TBL] [Abstract][Full Text] [Related]
4. Differential responses to challenge with live and dead Mycobacterium bovis Bacillus Calmette-Guérin.
Chambers MA; Marshall BG; Wangoo A; Bune A; Cook HT; Shaw RJ; Young DB
J Immunol; 1997 Feb; 158(4):1742-8. PubMed ID: 9029111
[TBL] [Abstract][Full Text] [Related]
5. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.
Fulton SA; Martin TD; Redline RW; Henry Boom W
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):333-43. PubMed ID: 10696070
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
[TBL] [Abstract][Full Text] [Related]
8. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells.
Demangel C; Bean AG; Martin E; Feng CG; Kamath AT; Britton WJ
Eur J Immunol; 1999 Jun; 29(6):1972-9. PubMed ID: 10382760
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
Forbes EK; Sander C; Ronan EO; McShane H; Hill AV; Beverley PC; Tchilian EZ
J Immunol; 2008 Oct; 181(7):4955-64. PubMed ID: 18802099
[TBL] [Abstract][Full Text] [Related]
10. The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects.
Oliveira FM; Trentini MM; Junqueira-Kipnis AP; Kipnis A
Mem Inst Oswaldo Cruz; 2016 Apr; 111(4):223-31. PubMed ID: 27074251
[TBL] [Abstract][Full Text] [Related]
11. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.
Mollenkopf HJ; Grode L; Mattow J; Stein M; Mann P; Knapp B; Ulmer J; Kaufmann SH
Infect Immun; 2004 Nov; 72(11):6471-9. PubMed ID: 15501778
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin.
Young S; O'Donnell M; Lockhart E; Buddle B; Slobbe L; Luo Y; De Lisle G; Buchan G
Immunol Cell Biol; 2002 Jun; 80(3):209-15. PubMed ID: 12067407
[TBL] [Abstract][Full Text] [Related]
13. Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guérin.
Daugelat S; Ladel CH; Kaufmann SH
Infect Immun; 1995 May; 63(5):2033-40. PubMed ID: 7537253
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation.
Wang J; Zganiacz A; Xing Z
Vaccine; 2002 Jul; 20(23-24):2887-98. PubMed ID: 12126899
[TBL] [Abstract][Full Text] [Related]
15. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.
Aldwell FE; Tucker IG; de Lisle GW; Buddle BM
Infect Immun; 2003 Jan; 71(1):101-8. PubMed ID: 12496154
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.
Lozes E; Denis O; Drowart A; Jurion F; Palfliet K; Vanonckelen A; De Bruyn J; De Cock M; Van Vooren JP; Huygen K
Scand J Immunol; 1997 Jul; 46(1):16-26. PubMed ID: 9246204
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.
Roberts AD; Sonnenberg MG; Ordway DJ; Furney SK; Brennan PJ; Belisle JT; Orme IM
Immunology; 1995 Jul; 85(3):502-8. PubMed ID: 7558141
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization.
Palendira U; Bean AG; Feng CG; Britton WJ
Infect Immun; 2002 Mar; 70(3):1410-6. PubMed ID: 11854227
[TBL] [Abstract][Full Text] [Related]
19. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.
Vordermeier HM; Chambers MA; Cockle PJ; Whelan AO; Simmons J; Hewinson RG
Infect Immun; 2002 Jun; 70(6):3026-32. PubMed ID: 12010994
[TBL] [Abstract][Full Text] [Related]
20. Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain.
Aguilar D; Infante E; Martin C; Gormley E; Gicquel B; Hernandez Pando R
Clin Exp Immunol; 2007 Feb; 147(2):330-8. PubMed ID: 17223975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
